Effect of 1-Time PSA Screening on Prostate Cancer Mortality

This cluster randomized trial evaluates the effect of a single prostate-specific antigen (PSA) screening test on 10-year prostate cancer –specific mortality among men aged 50 to 69 years treated at UK primary care practices.
Source: JAMA - Category: General Medicine Source Type: research